221 related articles for article (PubMed ID: 19826759)
1. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding.
Ruigrok YM; Slooter AJ; Rinkel GJ; Wijmenga C; Rosendaal FR
Acta Neurochir (Wien); 2010 Feb; 152(2):257-62. PubMed ID: 19826759
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Vergouwen MD; Frijns CJ; Roos YB; Rinkel GJ; Baas F; Vermeulen M
Stroke; 2004 Jun; 35(6):1280-3. PubMed ID: 15105509
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population.
Suvatha A; Sibin MK; Bhat DI; Narasingarao KVL; Vazhayil V; Chetan GK
BMC Med Genet; 2018 Sep; 19(1):159. PubMed ID: 30185149
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia.
Lanterna LA; Ruigrok Y; Alexander S; Tang J; Biroli F; Dunn LT; Poon WS
Neurology; 2007 Aug; 69(8):766-75. PubMed ID: 17709709
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhage.
Martini RP; Ward J; Siler DA; Eastman JM; Nelson JW; Borkar RN; Alkayed NJ; Dogan A; Cetas JS
J Neurosurg; 2014 Dec; 121(6):1359-66. PubMed ID: 25216066
[TBL] [Abstract][Full Text] [Related]
6. Search for genetic variants in the ryanodine receptor 1 gene in patients with symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Rueffert H; Gumplinger A; Renner C; Dengl M; Reske A; Kaisers UX; Meixensberger J
Neurocrit Care; 2011 Dec; 15(3):410-5. PubMed ID: 21503806
[TBL] [Abstract][Full Text] [Related]
7. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage.
Vermeij FH; Hasan D; Bijvoet HW; Avezaat CJ
Stroke; 1998 May; 29(5):924-30. PubMed ID: 9596236
[TBL] [Abstract][Full Text] [Related]
8. Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage.
Slowik A; Borratynska A; Turaj W; Pera J; Dziedzic T; Figlewicz DA; Betlej M; Krzyszkowski T; Czepko R; Szczudlik A
Stroke; 2005 Apr; 36(4):737-40. PubMed ID: 15718509
[TBL] [Abstract][Full Text] [Related]
9. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
[TBL] [Abstract][Full Text] [Related]
10. Prothrombotic gene variants and mortality after cerebral ischemia of arterial origin.
Pruissen DM; Rosendaal FR; Frijns CJ; Kappelle LJ; Vos HL; Algra A;
Neuroepidemiology; 2011; 37(2):109-13. PubMed ID: 21986109
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage.
Juvela S; Siironen J; Lappalainen J
J Neurosurg; 2009 May; 110(5):989-95. PubMed ID: 19199499
[TBL] [Abstract][Full Text] [Related]
12. Genes and outcome after aneurysmal subarachnoid haemorrhage.
Ruigrok YM; Slooter AJ; Bardoel A; Frijns CJ; Rinkel GJ; Wijmenga C
J Neurol; 2005 Apr; 252(4):417-22. PubMed ID: 15726267
[TBL] [Abstract][Full Text] [Related]
13. Endothelin polymorphisms as a risk factor for cerebral aneurysm rebleeding following aneurysmal subarachnoid hemorrhage.
Foreman PM; Starke RM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M; Griessenauer CJ
Clin Neurol Neurosurg; 2017 Jun; 157():65-69. PubMed ID: 28412541
[TBL] [Abstract][Full Text] [Related]
14. Association of Polymorphisms in Coagulation Factor Genes and Enzymes of Homocysteine Metabolism With Arterial Ischemic Stroke in Children.
Coen Herak D; Lenicek Krleza J; Radic Antolic M; Horvat I; Djuranovic V; Zrinski Topic R; Zadro R
Clin Appl Thromb Hemost; 2017 Nov; 23(8):1042-1051. PubMed ID: 28301901
[TBL] [Abstract][Full Text] [Related]
15. APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.
Lanterna LA; Rigoldi M; Tredici G; Biroli F; Cesana C; Gaini SM; Dalprà L
Neurology; 2005 Apr; 64(7):1238-44. PubMed ID: 15824354
[TBL] [Abstract][Full Text] [Related]
16. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage.
Brilstra EH; Rinkel GJ; Algra A; van Gijn J
Neurology; 2000 Dec; 55(11):1656-60. PubMed ID: 11113219
[TBL] [Abstract][Full Text] [Related]
17. Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage.
McIver JI; Friedman JA; Wijdicks EF; Piepgras DG; Pichelmann MA; Toussaint LG; McClelland RL; Nichols DA; Atkinson JL
J Neurosurg; 2002 Nov; 97(5):1042-4. PubMed ID: 12452133
[TBL] [Abstract][Full Text] [Related]
18. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage.
Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C
World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156
[TBL] [Abstract][Full Text] [Related]
19. Relation of serum TNF-α and TNF-α genotype with delayed cerebral ischemia and outcome in subarachnoid hemorrhage.
Beeftink MM; Ruigrok YM; Rinkel GJ; van den Bergh WM
Neurocrit Care; 2011 Dec; 15(3):405-9. PubMed ID: 21562930
[TBL] [Abstract][Full Text] [Related]
20. Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis.
Hu X; Xie Z; Zan X; Ma L; Li H; You C; Jiang Y
World Neurosurg; 2018 Oct; 118():e666-e676. PubMed ID: 30010064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
